What is GLP-1 microdosing?
GLP-1 receptor agonists — semaglutide and tirzepatide are the best-known — were developed and tested at standard dose-escalation schedules designed for maximum weight loss. "Microdosing" means using these medications at lower, individually tailored doses than those standard protocols, under provider supervision.
The idea isn't to get a smaller version of the same result. It's a different goal entirely: appetite balance, reduced food noise, steadier energy, and metabolic support — with a gentler experience and often fewer of the side effects that show up during aggressive dose escalation.
Because personalized low-dose regimens aren't commercially manufactured at these strengths and combinations, they're typically prepared for each patient by a state-licensed compounding pharmacy based on a provider's prescription. (Compounded medications are not FDA-approved — an important fact any honest provider will tell you plainly.)
Why would someone deliberately take a lower dose?
- Their goal isn't maximum weight loss. Many people want 10–15 pounds of change, appetite control, or metabolic support — not a clinical obesity intervention.
- Tolerability. Nausea and fatigue cluster around dose increases. Lower doses are chosen partly to minimize that experience.
- Maintenance. Some patients who reached their goal on standard dosing step down to a low dose rather than stopping entirely.
- The longevity frame. Interest in GLP-1s now extends beyond weight into appetite regulation, inflammation, and healthy-aging questions — areas where research is active and early.
What does the evidence actually say?
Here's the honest part: the large clinical trials behind GLP-1 medications studied standard dosing for weight loss and diabetes. Dedicated trials of low-dose protocols for energy, longevity, or "food noise" are limited — much of current practice is guided by clinical experience, known pharmacology, and patient-reported outcomes rather than large randomized studies.
That doesn't make microdosing illegitimate — medicine routinely individualizes dosing — but it does mean you should be skeptical of anyone promising specific outcomes from it. What a good provider can honestly offer: a personalized dose targeted at your goals, close follow-up, and adjustment based on how you actually respond.
Who it may fit — and who it doesn't
May fit: adults who want appetite and metabolic support without a maximum-dose protocol; people who found standard escalation hard to tolerate; goal-weight patients considering maintenance; wellness-oriented patients working with a provider on energy and healthspan.
Doesn't fit: anyone pregnant or nursing; people with a personal or family history of medullary thyroid carcinoma or MEN 2; anyone whose provider determines GLP-1 therapy isn't appropriate. A real intake process should screen for all of this — if a company will sell you GLP-1s without a licensed provider reviewing your health history, walk away.
What it costs
At Agave Longevity, GLP-1 microdosing programs run $179 per 4 weeks, or $169/month on a 12-week plan — all-inclusive of provider review, personalized medication if prescribed, and shipping. Programs combine low-dose semaglutide or tirzepatide with supportive ingredients like NAD+, B12, or L-carnitine depending on the goal. You won't be charged for medication if a provider determines you don't qualify.
Related reading: Oral semaglutide vs. injection · What compounded semaglutide costs in 2026